• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Achieve Life Sciences, Inc. - Common Shares (NQ:ACHV)

6.560 +0.090 (+1.39%)
Streaming Delayed Price Updated: 3:11 PM EDT, Aug 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Achieve Life Sciences, Inc. - Common Shares

< Previous 1 2 3 4 5 6 Next >
News headline image
Achieve Life Sciences Stockholders Weigh Board Slate, Share Increase at Annual Meeting ↗
July 09, 2026
Achieve Life Sciences (NASDAQ:ACHV) held its 2026 Annual Meeting of Stockholders virtually, with Chief Executive Officer Andrew Goldberg serving as chairperson of the meeting. Goldberg called the... 
Via MarketBeat
News headline image
Achieve (ACHV) Q1 2026 Earnings Transcript ↗
May 12, 2026
Achieve (ACHV) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics Intellectual Property
News headline image
Achieve Life Sciences Q1 Earnings Call Highlights ↗
May 12, 2026
Achieve Life Sciences (NASDAQ:ACHV) used its first-quarter 2026 earnings call to outline a transition period marked by new leadership, a major financing, manufacturing changes tied to its cytisinicline... 
Via MarketBeat
Topics Earnings
ACHV Stock Surges After Achieve Life Sciences Reports Market-Beating Q1 2026 Earnings ↗
May 12, 2026
Via Chartmill
Achieve Life Sciences Inc (NASDAQ:ACHV) Reports In-Line Q4 2025 Results, Announces Key Manufacturing Partnership ↗
March 24, 2026
Via Chartmill
News headline image
Earnings Scheduled For November 6, 2025 ↗
November 06, 2025
 
Via Benzinga
Achieve Life Sciences Stock Soars On Receiving FDA Voucher For Expediting Review Of Investigational Drug In Vaping Cessation ↗
October 17, 2025
Via Stocktwits
Keep an eye on the top gainers and losers in Thursday's session. ↗
April 16, 2026
Via Chartmill
What's going on in today's session ↗
April 16, 2026
Via Chartmill
Thursday's session: gap up and gap down stocks ↗
April 16, 2026
Via Chartmill
These stocks are moving in today's session ↗
March 24, 2026
Via Chartmill
News headline image
Hunterbrook Capital Bets Big on Achieve Life Sciences: Why a 'Toxic Tree' Could Disrupt the Multi-Billion Dollar Smoking Cessation Market
December 30, 2025
In a move that has sent ripples through the biotech sector on the final trading days of the year, Hunterbrook Capital announced a significant bullish position in Achieve Life Sciences (NASDAQ:ACHV)... 
Via MarketMinute
Topics Product Recall
News headline image
Achieve Life Sciences’ Smoking Treatment Likely To Be Approved By FDA, Says Hunterbrook ↗
December 30, 2025
The FDA is expected to rule on Achieve Life Sciences’ application seeking approval for the drug by June 20, 2026. 
Via Stocktwits
News headline image
Get insights into the top gainers and losers of Thursday's after-hours session. ↗
November 20, 2025
The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements. 
Via Chartmill
News headline image
Achieve Life Sciences Inc (NASDAQ:ACHV) Stock Rises on FDA Priority Voucher News Despite Wider-Than-Expected Loss ↗
November 06, 2025
Achieve Life Sciences stock rises on positive investor reaction to its Q3 2025 earnings and a key FDA Priority Voucher for its nicotine treatment. 
Via Chartmill
News headline image
4 Biotech Stocks Lifting Off As Momentum Builds ↗
October 21, 2025
Biotech stocks have trailed the broader market this year, but more names are starting to show strength as the rally expands and major indexes reach record levels. 
Via Benzinga
News headline image
Top movers in Friday's session ↗
October 17, 2025
Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
October 17, 2025
 
Via Benzinga
News headline image
Top stock movements in today's session. ↗
October 17, 2025
Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
News headline image
Which stocks are gapping on Friday? ↗
October 17, 2025
Traders are paying attention to the gapping stocks in Friday's session. Let's dive into which stocks are experiencing notable gaps. 
Via Chartmill
News headline image
The FDA Just Granted Its Speediest Review Ever. Disc Medicine, Others Fly. ↗
October 17, 2025
The Commissioner's National Priority Review vouchers aims to speed up the review process to just one to two months. 
Via Investor's Business Daily
News headline image
FDA Unveils First Experimental Drugs Under Fast-Track Voucher Plan To Cut Drug Review Times ↗
October 17, 2025
The FDA launched a new voucher program to fast-track reviews, naming nine experimental drugs for cancer, diabetes, addiction, and other conditions. 
Via Benzinga
News headline image
Discover the top movers in Friday's pre-market session. ↗
October 17, 2025
Before the US market kicks off on Friday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
News headline image
Why CSX Shares Are Trading Higher By Over 4%; Here Are 20 Stocks Moving Premarket ↗
October 17, 2025
 
Via Benzinga
News headline image
Revolution Medicines, Disc Medicine, Regeneron Stocks Jump After-Hours As FDA Fast-Tracks 9 Drugs Under New Review Program ↗
October 17, 2025
The FDA’s new National Priority Voucher pilot helps with faster drug reviews, cutting timelines from nearly a year to weeks. 
Via Stocktwits
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
October 16, 2025
 
Via Benzinga
News headline image
Which stocks are moving before the opening bell on Monday? ↗
August 25, 2025
Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session. 
Via Chartmill
News headline image
Achieve Life Sciences Inches Closer To FDA Nod For First New Quit-Smoking Drug In 20 Years ↗
August 21, 2025
HC Wainwright backs Achieve Life Sciences with a Buy rating as cytisinicline nears potential 2026 FDA approval, targeting a large smoking cessation market. 
Via Benzinga
News headline image
Achieve (ACHV) Q2 Net Loss Hits $12.7M ↗
August 07, 2025
Via The Motley Fool
News headline image
Achieve Life Sciences Inc (NASDAQ:ACHV) Reports Q2 2025 Results: Revenue in Line, Narrow EPS Beat Drives Pre-Market Gains ↗
August 07, 2025
Achieve Life Sciences reports Q2 2025 results with $0.0 revenue and -$0.37 EPS, meeting estimates. Shares rise 2.3% pre-market as focus remains on cytisinicline development for smoking cessation. 
Via Chartmill
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap